logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yuankai Shi

National Cancer Center
H指数:20
被引数:1,735

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, efficacy, and pharmacokinetics of eratrectinib (VC004) in solid tumors with NTRK fusions: phase 1 results from a phase 1/2 study

Eratrectinib（VC004）在NTRK融合阳性实体瘤中的安全性、有效性和药代动力学：一项Ⅰ/Ⅱ期研究的Ⅰ期结果

Experimental Hematology & Oncology
IF13.5
2026-06-260
OAAI
Shengyu Zhou; Changgong Zhang; Guowen Wang; Jun Qian; Gang Huang; Jiaqiang Wang; Suxia Luo; Youhua Zhu; Qingyuan Zhang; Ting Wei; Yongsheng Li; Zhendong Li; Dongyuan Zhu; Huarong Zhao; Meiyu Fang; Shoubing Zhou; Qing Xu; Yu Chen; Kejun Nan; Jiuwei Cui; Xueqiang Zhu; Yanchun Gong; Yong Wu; Xiaojuan Lai; Yuankai Shi
Establishing the China–UK Cancer Prevention and Control Alliance

建立中英癌症预防与控制联盟

lancet oncology
IF0
2025-09-010
PRE
Jun Ma; David Kerr; Yuankai Shi; Charles Swanton; Tony Mok; Rebecca Fitzgerald; Rui-Hua Xu; Richard Cowan; Rong Lin; Mark Lawler; Gao-Jun Teng; Tim Eisen; Molly Li; Maria Kyrgiou; Fanny Wai San Ko; Mark Middleton; Binghe Xu; Eric Aboyage; Dan Xiao; Yi-Long Wu; Arnie Puroshotham; Li Yang; Daiming Fan
Patient-reported outcomes for the phase 3 FURLONG study of furmonertinib versus ge fi tinib as fi rst-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer
LANCET REGIONAL HEALTH-WESTERN PACIFIC
IF8.1
2024-07-011
OAAI
Shi, Yuankai; Chen, Gongyan; Wang, Xiang; Liu, Yunpeng; Wu, Lin; Hao, Yanrong; Liu, Chunling; Zhu, Shuyang; Zhang, Xiaodong; Li, Yuping; Liu, Jiwei; Cao, Lejie; Cheng, Ying; Zhao, Hui; Zhang, Shucai; Zang, Aimin; Cui, Jiuwei; Feng, Jian; Yang, Nong; Hu, Jie; Liu, Fei; Jiang, Yong; Ge, Nan
Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase II study

抗EGFR单克隆抗体SCT200在氟尿嘧啶，伊立替康和奥沙利铂难治性RAS和BRAF野生型转移性结直肠癌患者中的疗效，安全性和基因组分析: II期研究

EBIOMEDICINE
IF10.8
2024-02-010
OAAI
Yang, Lin; Zhang, Wen; Fan, Nanfeng; Cao, Peiguo; Cheng, Ying; Zhu, Lingjun; Luo, Suxia; Zong, Hong; Bai, Yuxian; Zhou, Jianfeng; Deng, Yanhong; Ba, Yi; Liu, Tianshu; Aili, Mayinuer; Yin, Xianli; Gu, Kangsheng; Dai, Guanghai; Ying, Jieer; Shi, Jianhua; Gao, Yajie; Li, Wei; Yu, Guohua; Xie, Liangzhi; Gai, Wenlin; Wang, Yan; Meng, Peng; Shi, Yuankai

研究方向

暂未获取到该数据
韩晓红 封面图
韩晓红
H 指数:32论文数:369被引数:4,167
L
Le Tang
H 指数:24论文数:225被引数:2,728
J
Jiarui Yao
H 指数:15论文数:173被引数:1,104
T
Tongji Xie
H 指数:13论文数:91被引数:532
G
Guangyu Fan
H 指数:8论文数:34被引数:313
Y
Yu Zhou
H 指数:20论文数:91被引数:1,206
S
Sheng Yang
H 指数:20论文数:170被引数:1,340
J
Jianliang Yang
H 指数:21论文数:158被引数:1,551
Z
Zhishang Zhang
H 指数:11论文数:120被引数:475
H
Haizhu Chen
H 指数:14论文数:70被引数:526